COMBINATION OF ANTI-CTLA4 ANTIBODY WITH DIVERSE THERAPEUTIC REGIMENS FOR THE SYNERGISTIC TREATMENT OF PROLIFERATIVE DISEASES

• 收藏
• 分享

专利权人:

BRISTOL-MYERS SQUIBB COMPANY

发明人:

LEE, Francis Y.,JURE-KUNKEL, Maria

申请号：

AU2015203322

公开号：

AU2015203322B2

申请日:

2015.06.17

申请国别(地区):

AU

年份:

2016

代理人:

摘要：

#$%^&*AU2015203322B220160929.pdf#####ABSTRACT Compositions and methods for the treatment and prevention of proliferative disorders comprising, inter alia, an anti-CTLA-4 agent, such as ipilimumab or tremelimumab, in combination with other chemotherapeutic agents, such as dasatinib, imatinib, paclitaxel, gemcitabine, cisplatin or etoposide. In particular, a method of treating cancer comprising the administration of an anti-CTLA-4 antibody with gemcitabine.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/